Article
HER-2 amplification but not butyrylcholinesterase multability reflects aggressiveness of European-originated ovarian tumors.
Gynecologic oncology - 1 Feb 1995
Dobianer K, Hruza C, Ehrlich G, Sevelda P, Czerwenka K, Soreq H, Spona J, Zakut H
Abstract excerpt
Tumorigenic roles were variably suggested for HER-2 and INT-2 oncogene amplifications and the "atypical" aspartate to glycine mutability in the butyrylcholinesterase (BCHE) gene in ovarian adenocarcinomas. To examine this notion we searched for correlations between these three phenomena and ovarian tumor classification and aggressiveness, using quantitative polymerase chain reaction (PCR), single-strand...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.